![Caroline Loewy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Caroline Loewy
Direttore/Membro del Consiglio presso
Kcnq2 Cure Alliance, Inc.
Profilo
Caroline M.
Loewy is the founder of Achieve Life Sciences, Inc., which was founded in 1991.
She held the title of Chief Financial & Business Officer from 2015 to 2017.
Ms. Loewy's current jobs include being a Director at Kcnq2 Cure Alliance, Inc. since 2014 and a Founding Director at Global Genes since 2009.
Ms. Loewy's former jobs include being an Independent Director at PhaseBio Pharmaceuticals, Inc. from 2018 to 2023, an Independent Director at Zogenix, Inc. from 2020 to 2022, an Independent Director at Locust Walk Acquisition Corp.
in 2021, an Independent Director at CymaBay Therapeutics, Inc. from 2016 to 2024, a Director at Aptose Biosciences, Inc. from 2018 to 2022, an Independent Director at eFFECTOR Therapeutics, Inc. from 2023 to 2024, and the Chief Financial Officer at Poniard Pharmaceuticals, Inc. from 2006 to 2008.
She was also the Chief Financial Officer at Corcept Therapeutics, Inc. from 2008 to 2011 and Tobira Therapeutics, Inc. from 2012 to 2014.
Additionally, she worked at Prudential Securities from 1996 to 1999 and Morgan Stanley & Co. LLC from 2000 to 2004.
Ms. Loewy's education includes a graduate degree and an MBA from Carnegie Mellon University.
She also has an undergraduate degree from the University of California, Berkeley, which was conferred in 1988.
Posizioni attive di Caroline Loewy
| Società | Posizione | Inizio |
|---|---|---|
Kcnq2 Cure Alliance, Inc.
 Kcnq2 Cure Alliance, Inc. Kcnq2 Cure Alliance, Inc. is a nonprofit organization that supports individuals and families affected by KCNQ2-related disorders, which are rare genetic neurological conditions caused by mutations in the KCNQ2 gene that primarily lead to neonatal seizures and developmental challenges. The private company is based in Denver, CO. The alliance focuses on education, advocacy, research funding, and community support to improve understanding, treatment, and outcomes for those impacted. It provides resources for families, caregivers, clinicians, and researchers, including educational materials, caregiver support programs, medical and school resources, and guidance on managing the condition. The organization facilitates participation in clinical trials, observational studies, and natural history research, promotes data sharing, maintains a biorepository of biological samples, and supports research using genetic mouse models and patient-derived cell lines. It leads awareness initiatives, fosters international collaboration, offers grant programs to fund research, publishes weekly research updates, and encourages community engagement through fundraising, volunteering, and sharing personal stories. | Direttore/Membro del Consiglio | 01/10/2014 |
Global Genes
 Global Genes Miscellaneous Commercial ServicesCommercial Services Operates organization for promoting rare diseases and advocacy services | Direttore/Membro del Consiglio | 01/06/2009 |
Precedenti posizioni note di Caroline Loewy
| Società | Posizione | Fine |
|---|---|---|
| EFFECTOR THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 21/06/2024 |
| CYMABAY THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 22/03/2024 |
Phoenix Biotech Acquisition Corp.
 Phoenix Biotech Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Direttore/Membro del Consiglio | 29/02/2024 |
| PHASEBIO PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 27/09/2023 |
| APTOSE BIOSCIENCES INC. | Direttore/Membro del Consiglio | 30/06/2022 |
Formazione di Caroline Loewy
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
95
Relazioni di 1° grado
17
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 17 |
|---|---|
Poniard Pharmaceuticals, Inc.
 Poniard Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic biopharmaceuticals, primarily for the treatment of cancer, cardiovascular and inflammatory diseases | Health Technology |
Aptose Biosciences, Inc.
 Aptose Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, research and develops anticancer therapies with high safety profiles | Health Technology |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prudential Securities
 Prudential Securities Investment Banks/BrokersFinance Provides brokerage services | Finance |
Corcept Therapeutics, Inc.
 Corcept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of drugs which treat severe metabolic, oncologic and neuropsychiatric disorders | Health Technology |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
PhaseBio Pharmaceuticals, Inc.
 PhaseBio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapies for cardiovascular diseases | Health Technology |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets medicines | Health Technology |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tobira Therapeutics, Inc. /Old/
 Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company, which develops and commercializes antiviral products | Health Technology |
Kcnq2 Cure Alliance, Inc.
Kcnq2 Cure Alliance, Inc. Kcnq2 Cure Alliance, Inc. is a nonprofit organization that supports individuals and families affected by KCNQ2-related disorders, which are rare genetic neurological conditions caused by mutations in the KCNQ2 gene that primarily lead to neonatal seizures and developmental challenges. The private company is based in Denver, CO. The alliance focuses on education, advocacy, research funding, and community support to improve understanding, treatment, and outcomes for those impacted. It provides resources for families, caregivers, clinicians, and researchers, including educational materials, caregiver support programs, medical and school resources, and guidance on managing the condition. The organization facilitates participation in clinical trials, observational studies, and natural history research, promotes data sharing, maintains a biorepository of biological samples, and supports research using genetic mouse models and patient-derived cell lines. It leads awareness initiatives, fosters international collaboration, offers grant programs to fund research, publishes weekly research updates, and encourages community engagement through fundraising, volunteering, and sharing personal stories. | |
Global Genes
Global Genes Miscellaneous Commercial ServicesCommercial Services Operates organization for promoting rare diseases and advocacy services | Commercial Services |
Achieve Life Sciences, Inc.
 Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
Locust Walk Acquisition Corp.
 Locust Walk Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
eFFECTOR Therapeutics, Inc.
 eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer | Health Technology |
Phoenix Biotech Acquisition Corp.
Phoenix Biotech Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
